REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Clideol CIA Ltda (Ecuador)

Main Activities: Offices of Physicians
Full name: Clideol CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Clideol CIA Ltda is an ophthalmology company. They offer services such as cornea transplants, refractive surgery, and laser-assisted cataract surgery. The company has a team of professional ophthalmologists specialized in refractive surgery. They have high-tech campometer and ultrasound equipment for precise measurements and calculations. The company is also known for its expertise in comprehensive handling of Queratocone and refractive defects.

Headquarters
Pasaje los Angeles E4-14, Da Vinci Bldg. , Floor 302
Quito; Pichincha;

Contact Details: Purchase the Clideol CIA Ltda report to view the information.

Website: http://www.larcovision.com

Basic Information
Total Employees:
Purchase the Clideol CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Clideol CIA Ltda report to view the information.
Registered Capital:
Purchase the Clideol CIA Ltda report to view the information.
Incorporation Date:
July 12, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
33.4%
Purchase this report to view the information.
33.3%
Purchase this report to view the information.
33.3%
Company Performance
Financial values in the chart are available after Clideol CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.07%▼
Total operating revenue
-13.07%▼
Operating profit (EBIT)
N/A
EBITDA
-60.93%▼
Net Profit (Loss) for the Period
N/A
Total assets
-5.38%▼
Total equity
-2.49%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.73%▼
Quick Ratio
0.16%▲
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo